Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?

Despite recent advances in tumor imaging and chemoradiotherapy, the median overall survival of patients diagnosed with glioblastoma multiforme does not exceed 15 months. Infiltration of glioma cells into the brain parenchyma, and the blood-brain barrier are important hurdles to further increase the...

Descripción completa

Detalles Bibliográficos
Autores principales: van Woensel, Matthias, Wauthoz, Nathalie, Rosière, Rémi, Amighi, Karim, Mathieu, Véronique, Lefranc, Florence, van Gool, Stefaan W., de Vleeschouwer, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795377/
https://www.ncbi.nlm.nih.gov/pubmed/24202332
http://dx.doi.org/10.3390/cancers5031020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795377/
https://www.ncbi.nlm.nih.gov/pubmed/24202332
http://dx.doi.org/10.3390/cancers5031020

Ejemplares similares